Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Low Protein, Extensively Hydrolyzed Infant Formula on Allergy Prevention in At-risk Infants up to 1 Year of Age: a Randomized, Double-blind, Controlled Intervention Study and the Long-term Effect on Allergy Prevention of Early Nutrition Given in the First 120 Days of Life in At-risk Infants Until the Child is 6 Years of Age

NCT03489733 is registered in ClinicalTrials.gov with HiPP GmbH & Co. Vertrieb KG as lead sponsor.

NCT NCT03489733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03489733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Low Protein, Extensively Hydrolyzed Infant Formula on Allergy Prevention in At-risk Infants up to 1 Year of Age: a Randomized, Double-blind, Controlled Intervention Study and the Long-term Effect on Allergy Prevention of Early Nutrition Given in the First 120 Days of Life in At-risk Infants Until the Child is 6 Years of Age
Lead sponsor
HiPP GmbH & Co. Vertrieb KG
Phase
Not applicable
Overall status
Completed
Start date
July 9, 2018
Completion date
October 30, 2025
Enrollment
1,226 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

atopic diseases